Voyager Therapeutics, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Voyager Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $57.00K, a 27.85% decline year-over-year.
- Voyager Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $294.00K, a 258.54% increase year-over-year.
- Voyager Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $85.00K, a 7.61% decline year-over-year.
- Voyager Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $79.00K, a 12.22% decline year-over-year.
- Voyager Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $267.00K, a 31.19% decline from fiscal 2024.
- Voyager Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $388.00K, a 79.05% decline from fiscal 2023.
- Voyager Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $1.85M, a 194.44% increase from fiscal 2022.
- Voyager Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $629.00K, a 2146.43% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $57.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $294.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $267.00K 10-K · filed 2026-03-09 | |
| 2025-09-30 | $85.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $79.00K 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $82.00K 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $388.00K 10-K · filed 2026-03-09 | |
| 2024-09-30 | $92.00K 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $90.00K 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $78.00K 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $1.85M 10-K · filed 2026-03-09 | |
| 2023-09-30 | $415.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $1.23M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $185.00K 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $629.00K 10-K · filed 2025-03-11 | |
| 2022-09-30 | $15.00K 10-Q · filed 2023-11-06 | |
| 2022-06-30 | $575.00K 10-Q · filed 2023-11-06 | |
| 2022-03-31 | $12.00K 10-Q · filed 2023-11-06 | |
| 2021-12-31 | $28.00K 10-K · filed 2024-02-28 | |
| 2021-03-31 | $28.00K 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $2.32M 10-K · filed 2023-03-07 | |
| 2020-09-30 | $510.00K 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $1.65M 10-Q · filed 2021-11-02 | |
| 2020-03-31 | $34.00K 10-Q · filed 2021-11-02 | |
| 2019-12-31 | $2.71M 10-K · filed 2022-03-08 | |
| 2019-09-30 | $1.61M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $714.00K 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $284.00K 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $3.89M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $945.00K 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $1.12M 10-Q · filed 2019-11-06 | |
| 2018-03-31 | $1.41M 10-Q · filed 2019-11-06 | |
| 2017-12-31 | $1.36M 10-K · filed 2020-03-03 | |
| 2016-12-31 | $514.00K 10-K · filed 2019-02-26 | |
| 2015-12-31 | $10.00K 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |